Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain; Biochemical and Molecular Genetics Service, Department of Dermatology, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain.
Br J Dermatol. 2013 Oct;169(4):804-11. doi: 10.1111/bjd.12418.
Cutaneous melanoma tumour is classified into clinicohistopathological subtypes that may be associated with different genetic and host factors. Variation in the MC1R gene is one of the main factors of risk variation in sporadic melanoma. The relationship between MC1R variants and the risk of developing a specific subtype of melanoma has not been previously explored.
To analyse whether certain MC1R variants are associated with particular melanoma subtypes with specific clinicohistopathological features.
An association study was performed between MC1R gene variants and clinicopathological subtypes of primary melanoma derived from 1679 patients.
We detected 53 MC1R variants (11 synonymous and 42 nonsynonymous). Recurrent nonsynonymous variants were p.V60L (30·0%), p.V92M (11·7%), p.D294H (9·4%), p.R151C (8·8%), p.R160W (6·2%), p.R163Q (4·2%) p.R142H (3·3%), p.I155T (3·8%), p.V122M (1·5%) and p.D84E (1·0%). Melanoma subtypes showed differences in the total number of MC1R variants (P = 0·028) and the number of red hair colour variants (P = 0·035). Furthermore, an association between p.R163Q and lentigo maligna melanoma was detected under a dominant model of heritance (odds ratio 2·16, 95% confidence interval 1·07-4·37; P = 0·044). No association was found between p.R163Q and Fitzpatrick skin phototype, eye colour or skin colour, indicating that the association was independent of the role of MC1R in pigmentation. No association was observed between MC1R polymorphisms and other melanoma subtypes.
Our findings suggest that certain MC1R variants could increase melanoma risk due to their impact on pathways other than pigmentation, and may therefore be linked to specific melanoma subtypes.
皮肤黑色素瘤肿瘤分为临床组织病理学亚型,这些亚型可能与不同的遗传和宿主因素有关。MC1R 基因的变异是散发性黑色素瘤风险变异的主要因素之一。MC1R 变体与特定黑色素瘤亚型发生风险之间的关系尚未被探索。
分析某些 MC1R 变体是否与具有特定临床组织病理学特征的特定黑色素瘤亚型相关。
对来自 1679 例患者的原发性黑色素瘤的 MC1R 基因变体与临床组织病理学亚型进行了关联研究。
我们检测到 53 种 MC1R 变体(11 种同义变体和 42 种非同义变体)。反复出现的非同义变体为 p.V60L(30.0%)、p.V92M(11.7%)、p.D294H(9.4%)、p.R151C(8.8%)、p.R160W(6.2%)、p.R163Q(4.2%)、p.R142H(3.3%)、p.I155T(3.8%)、p.V122M(1.5%)和 p.D84E(1.0%)。黑色素瘤亚型在 MC1R 变体总数(P=0.028)和红发变体数量(P=0.035)方面存在差异。此外,在显性遗传模式下,检测到 p.R163Q 与原位黑素瘤之间存在关联(优势比 2.16,95%置信区间 1.07-4.37;P=0.044)。p.R163Q 与 Fitzpatrick 皮肤光型、眼睛颜色或皮肤颜色之间没有关联,表明这种关联独立于 MC1R 在色素沉着中的作用。MC1R 多态性与其他黑色素瘤亚型之间没有关联。
我们的研究结果表明,某些 MC1R 变体可能会因对除色素沉着以外的途径产生影响而增加黑色素瘤的风险,因此可能与特定的黑色素瘤亚型有关。